The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

Chao Dong(Kunming Medical University), Marie C.M. Lin(Shenzhen University)

International Journal of Biological Sciences

January 1, 2019

10.7150/ijbs.32625

Cited by 35

Related Papers

In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

|PLoS ONE|2015|85

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

|Molecular Medicine Reports|2015|63

Adenosine diphosphate‐ribosylation factor 6 is required for epidermal growth factor‐induced glioblastoma cell proliferation

|Cancer|2009|34

Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells

|Scientific Reports|2017|21

Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma

|Molecular Medicine|2021|12